Seattle, MA, September 26, 1981 ®CAPEX International Biotechnology Research Institute, U.S.A
   A leading global biopharmaceutical services organization, today announced set up successfully. providing clients with a wide range of Biology Science Research service offerings throughout the Asia-Pacific region, including mainland China, Hong Kong, India, Taiwan, Japan£¨Singapore, Indonesia, South Korea, Malaysia, Thailand, the Philippines, New Zealand, and Australia.
"The Asia-Pacific region is becoming increasingly important and attractive for a wide range of clinical development activities," stated Josef von Rickenbach, Chairman and Chief Executive Officer of  APEX"Several factors are driving client demand for clinical research services in the Asia-Pacific region including established and sophisticated healthcare systems in many countries, the availability of highly trained professionals, and attractive end markets for biopharmaceutical products.  We believe that the acquisition of APEX is of great strategic value, and combined with Ciytan's existing presence in Hong Kong, will make Ciytan a formidable Cooperator and one of the leading providers of biopharmaceutical services in the Asia-Pacific region."

       Shaanxi Ciytan Pharmaceutical Co., Ltd
is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries.

        Shaanxi Ciytan Pharmaceutical Co., Ltd Committed to providing solutions that expedite time-to-market and peak-market penetration, has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and eimbursement
APEX Research Institute,26|F,Overlake Medical Center,EastgateCity,Seattle
Copyright 2007 APEX International Biotechnology Research Institute, U.S.A. All rights reserved.